New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.

Source:http://linkedlifedata.com/resource/pubmed/id/18035244

Download in:

View as

Triples

General Info

PMID
18035244